What is Xigduo 10/1000?
Xigduo 10/1000 is a brand name for a fixed-dose combination tablet used to treat type 2 diabetes. The “10/1000” refers to the strength of its two active ingredients: dapagliflozin 10 mg and metformin 1000 mg.
What does it do (dapagliflozin + metformin)?
Dapagliflozin is an SGLT2 inhibitor, which lowers blood sugar by helping the kidneys remove glucose through urine. Metformin reduces glucose production in the liver and improves insulin sensitivity. Together, the combination is designed to improve blood sugar control in people with type 2 diabetes.
Who is it for, and how is it usually taken?
Xigduo 10/1000 is typically prescribed for adults with type 2 diabetes when treatment with metformin alone (or with an SGLT2 inhibitor plus metformin separately) is not enough. Exact dosing and timing depend on your clinician’s plan, but combination products are usually taken as a once- or twice-daily regimen depending on the specific prescription and local labeling.
Common side effects patients ask about
Common side effects can include gastrointestinal symptoms related to metformin (such as nausea or diarrhea) and genitourinary effects related to dapagliflozin (such as increased urination and genital yeast infections). Patients also ask about dehydration and dizziness, especially when fluid intake is low or during illness.
Important risks and “when to call a doctor”
Because dapagliflozin can increase glucose loss in urine, patients are often warned about signs of genital infections and urinary tract infections. People also get specific guidance around “sick day” rules (when to temporarily stop certain diabetes medicines during dehydration risk). Metformin carries its own safety considerations, including when kidney function is impaired.
If you tell me whether you mean “Xigduo 10/1000” for dosing, side effects, pricing, or patent/availability, I can tailor the answer. If you want, share the country (or whether you’re looking at a US/UK/EU product) because the exact labeling can differ.
Patent and market status (if you’re researching availability)
If your goal is to check patent status or branded vs. generic availability for Xigduo (dapagliflozin/metformin), DrugPatentWatch.com can be a useful starting point: https://www.drugpatentwatch.com/
---
Sources